News/ News/ Oncology Bayer props up sagging radionuclide business with Noria acquisition Phil Taylor Bayer, M&A, Oncology, Prostate cancer, radionuclide, Radiopharmaceutical 0 Comment Bayer has agreed to buy Noria Therapeutics and its subsidiary PSMA Therapeutics, adding to its pipeline of radionuclide Share X Bayer props up sagging radionuclide business with Noria acquisition https://pharmaphorum.com/news/bayer-props-up-sagging-radionuclide-business-with-noria-acquisition/